Home » Newsletters » BioWorld Asia

BioWorld Asia

May 13, 1998

View Archived Issues

GlycoDesign Raises C$13M For Enzyme Inhibitor Work

Brain Peptide Discovery Shows Promise For Obesity Control

Tyrphostins Attack Restenosis, Work Against Brain Cancer

Encapsulated Cell Therapy Draws US$8M For Modex

Antisoma Takes Over Company Formed With Cancer Charity

Peptide Therapeutics Signs Vaccine Deal With Pasteur

Skin Cancer Vaccine Study 'Personalizes' Drug To Patient

Devgen, Janssen Partnering; Plan More Worm Research

Mucin, Sugar Cancer Vaccine Moving Into Phase I/II Trials

Therapeutic Antibodies Seeks Antivenom Product Approval

Alltracel Tumor Study Reports Positive Data

Irish Research Prize Awarded To Bug Hunter

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...